These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21769632

  • 1. First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.
    Ge YP, He GX, Lin T, Lu GX, Shen YN, Liu WD.
    Mycopathologia; 2011 Dec; 172(6):465-71. PubMed ID: 21769632
    [Abstract] [Full Text] [Related]

  • 2. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait.
    Ahmad S, Khan Z, Mokaddas E, Khan ZU.
    J Med Microbiol; 2004 Jul; 53(Pt 7):633-637. PubMed ID: 15184534
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
    Ahmad S, Mokaddas E, Al-Sweih N, Khan ZU.
    Med Princ Pract; 2005 Jul; 14 Suppl 1():77-83. PubMed ID: 16103717
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
    Mokaddas E, Khan ZU, Ahmad S.
    Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.
    Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K.
    J Clin Microbiol; 2001 Dec; 39(12):4309-15. PubMed ID: 11724837
    [Abstract] [Full Text] [Related]

  • 10. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects.
    Giammanco GM, Pizzo G, Pecorella S, Distefano S, Pecoraro V, Milici ME.
    Oral Microbiol Immunol; 2002 Apr; 17(2):89-94. PubMed ID: 11929555
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.
    Ellepola AN, Hurst SF, Elie CM, Morrison CJ.
    Oral Microbiol Immunol; 2003 Dec; 18(6):379-88. PubMed ID: 14622344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
    Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait.
    Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R.
    Mycoses; 2005 Sep; 48(5):347-51. PubMed ID: 16115107
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.